Necina Roman 4
4 · HOOKIPA Pharma Inc. · Filed Dec 11, 2019
Insider Transaction Report
Form 4
Necina Roman
Chief Technology Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-12-09+125,008→ 125,008 totalExercise: $8.21Exp: 2029-12-09→ Common Stock (125,008 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on December 9, 2020, with the remainder vesting in 12 equal quarterly installments thereafter.